Topics

AbbVie reportedly drops global patent rights for HIV drug

08:16 EDT 25 Mar 2020 | SmartBrief

AbbVie will reportedly give up global patent rights for its HIV drug Kaletra, which is being evaluated in several clinical tr -More

Original Article: AbbVie reportedly drops global patent rights for HIV drug

NEXT ARTICLE

More From BioPortfolio on "AbbVie reportedly drops global patent rights for HIV drug"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...